Edgewise Therapeutics (EWTX) PT Lowered to $29 at RBC Capital

November 4, 2022 6:31 AM EDT Send to a Friend
RBC Capital analyst Leonid Timashev ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login